1 |
Bonder A, Afdhal N. Evaluation of liver lesions [J]. Clin Liver Dis, 2012, 16(2): 271-283.
|
2 |
Dietrich CF, Tannapfel A, Jang HJ, et al. Ultrasound imaging of hepatocellular adenoma using the new histology classification [J]. Ultrasound Med Biol, 2019, 45(1): 1-10.
|
3 |
Lo RC. Epithelioid angiomyolipoma of the liver: a clinicopathologic study of 5 cases [J]. Ann Diagn Pathol, 2013, 17(5): 412-415.
|
4 |
Zou MH, Huang Q, Zou Q, et al. Clinical and contrast-enhanced ultrasound characteristics of epithelioid and classic hepatic angiomyolipoma: comparison with alpha-fetoprotein-negative hepatocellular carcinoma [J]. Ultrasound Med Biol, 2021, 47(3): 446-453.
|
5 |
陈凯玲, 张炜彬, 毛枫, 等. 超声造影诊断炎症型肝细胞腺瘤的临床应用 [J]. 中华超声影像学杂志, 2021, 30(1): 48-53.
|
6 |
Huang WC, Liau JY, Jeng YM, et al. Hepatocellular adenoma in taiwan: distinct ensemble of male predominance, overweight/obesity, and inflammatory subtype [J]. J Gastroenterol Hepatol, 2020, 35(4): 680-688.
|
7 |
Nault JC, Paradis V, Cherqui D, et al. Molecular classification of hepatocellular adenoma in clinical practice [J]. J Hepatol, 2017, 67(5): 1074-1083.
|
8 |
Socas L, Zumbado M, Perez-Luzardo O, et al. Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature [J]. Br J Sports Med, 2005, 39(5): e27.
|
9 |
Mouhoub M, Miry A, Haloui A, et al. Malignant transformation of hepatocellular adenoma: report of a case [J]. Pan Afr Med J, 2020, 35: 92.
|
10 |
Dhingra S, Fiel MI. Update on the new classification of hepatic adenomas: clinical, molecular, and pathologic characteristics [J]. Arch Pathol Lab Med, 2014, 138(8): 1090-1097.
|
11 |
Nault J, Couchy G, Balabaud C, et al. Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation [J]. Gastroenterology, 2017, 152(4): 880-894.
|
12 |
杨秋霞, 张嵘, 吴静, 等. 肝细胞腺瘤的影像学表现与组织病理学的相关性 [J]. 中国CT和MRI杂志, 2013, 11(1): 48-52, 71.
|
13 |
Lee SJ, Kim SY, Kim KW, et al. Hepatic angiomyolipoma versus hepatocellular carcinoma in the noncirrhotic liver on gadoxetic acid-enhanced mri: a diagnostic challenge [J]. AJR Am J Roentgenol, 2016, 207(3): 562-570.
|
14 |
Sandulescu L, Saftoiu A, Dumitrescu D, et al. Real-time contrast-enhanced and real-time virtual sonography in the assessment of benign liver lesions [J]. J Gastrointestin Liver Dis, 2008, 17(4): 475-478.
|
15 |
Garcovich M, Faccia M, Meloni F, et al. Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an italian multicenter experience [J]. J Ultrasound, 2019, 22(2): 157-165.
|
16 |
Dietrich CF, Nolsoe CP, Barr RG, et al. Guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (ceus) in the liver-update 2020 wfumb in cooperation with efsumb, afsumb, aium, and flaus [J]. Ultrasound Med Biol, 2020, 46(10): 2579-2604.
|